Skip to main content

$0.075 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
5 June 2026 at 2:23am
Register to track PAA and receive email alerts.

MND Trial Completes Enrolment of Cohort 2

StockBot

416,823 posts

PAA released this announcement to the ASX on 30 March 2023, 9:17. The announcement is marked as price sensitive, and is 2 page(s) in length and 209.15kb in size.

You can view all announcements from PAA and see how they appear on a price chart on the announcements page.

At the date of this announcement, PAA was 0.072% short sold according to ASIC data. It was ranked the 487th most shorted stock on the ASX. It remains ranked 492nd as of the latest reported data (11 October 2024).

Other Recent Announcements from PAA
Results of General Meeting 30 June 2023, 12:38
Trading Halt 30 June 2023, 9:48
General Meeting - Chairman Script 30 June 2023, 9:42
MND Trial Completes Enrolment of Cohort 2 30 March 2023, 9:17
Stable Patient in MND trial reaches 6-months on MPL 28 March 2023, 9:21
PharmAust Investor Webinar Presentation 16 March 2023, 8:13
AOG Energy Conference Presentation 15 March 2023, 19:35
You must login or register to post a comment.

You must be logged in to post a reply.

Register to track PAA and receive email alerts.